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Background: Listeriosis is a fatal disease caused by pathogenic Listeria bacteria and it is most prevalent in
immune-compromised individuals. The increase in numbers of immune-compromised individuals against a
background of Listeria antibiotic resistance, limits listeriosis treatment options. This therefore calls for research into
substitute treatments, of which, medicinal plants derived compounds offer a viable alternative.
Methods: The broth microdilution assay was used to determine the minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC) of three plant triterpenes namely 3β-hydroxylanosta-9,24-dien-21-oic
acid, methyl-3β-hydroxylanosta-9,24-dien-21-oate and 3β-acetylursolic acid, against Listeria monocytogenes, Listeria
ivanovii and Listeria grayi species. The chequerboard method was used to assess the interactions between the
triterpenes and conventional antibiotics: ampicillin, neomycin, gentamicin and penicillin G. The lactate dehydrogenase
membrane damage method was used to assess the triterpenes’ membrane damaging potentials against the
Listeria bacteria.
Results: The triterpenes’ MIC values were found to range from 0.185 to 1.67 mg/ml while, the MBC
determination assay results revealed that the test triterpenes were bacteriostatic against the Listeria bacteria. The
interactions involving 3β-hydroxylanosta-9,24-dien-21-oic acid were mainly additive with ampicillin and
synergistic with neomycin, gentamicin and penicillin G. The interactions involving methyl-3β-hydroxylanosta-9,
24-dien-21-oate were mainly antagonistic with ampicillin, indifferent with neomycin, ranging from synergistic to
indifference with gentamicin and synergistic with penicillin G. The interactions involving 3β-acetylursolic acid
were mainly indifferent with ampicillin, synergistic with neomycin and gentamicin while ranging between
synergistic and additive with penicillin G. The low levels of cytosolic lactate dehydrogenase released from the
cells treated with 4× MIC concentration of the triterpenes in comparison to that of cells treated with 3% Triton X-100
proved that membrane damage was not the mode of action of the triterpenes.
Conclusion: This study therefore shows the potential that these plant triterpenes have in listeriosis chemotherapy
especially as shown by the favourable interactions they had with penicillin G, one of the antibiotics of choice in
listeriosis treatment.
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There are currently fifteen known Listeria species [1], but
only two of the species are known to be pathogenic;
L. monocytogenes is pathogenic to humans and animals
while L. ivanovii is pathogenic to animals only. L. monocy-
togenes causes the human fatal disease listeriosis with a
case fatality rate of 20-30%; the disease can be in either of
two forms, gastrointestinal non-invasive listeriosis which
is usually self-limiting or the invasive listeriosis which can
be fatal [2].
Contaminated foods such as raw vegetables, meats and
ready to eat foods are the major source of pathogenic
Listeria, such that the gastrointestinal tract is the bacte-
ria’s primary site of entry [3]. The bacteria then colonises
the intestine leading to intestinal translocation and at
this stage the listeriosis is non-invasive however, if the
immune system does not control the infection, the lis-
teriosis progresses to become invasive as the pathogen
disseminates to the bloodstream and mesenteric lymph
nodes [2,4]. The bacterium may then replicate in the
liver and spleen, such that control of the bacterium at
this point is dependent upon T cell-mediated immunity.
However, in immune-compromised individuals the Lis-
teria spreads to the central nervous system or in the
case of pregnant women it crosses the placental barrier
resulting in infection of the foetus [2,4,5].
The pathogenic Listeria has an intracellular life cycle
that includes invading host cells by using adhesion pro-
teins internalin A and internalin B to bind to the host-cell
membrane receptors E-cadherin and Met, replication in
the cytoplasm after phagosomal escape and cell to cell
spread through ActA surface proteins’ polymerization of
actin [6,7].
Ampicillin and penicillin G are the first line drugs of
choice for listeriosis treatment, with them being used in
combination with an aminoglycoside mostly gentamicin
in high risk patients (neonates aged less than 1 month,
the elderly, immune-compromised individuals, pregnant
women). Meropenem may be used in patients with mild
allergies to penicillin, while sulfamethoxazole in combin-
ation with trimethoprim or vancomycin in combination
with teicoplanin can be used in patients with severe
allergies [7,8].
The administration of appropriate and effective anti-
biotic therapy in high-risk patients to prevent invasive
listeriosis is imperative [7]. A number of factors have how-
ever, limited listeriosis treatment options. The factors in-
clude; the characteristic life cycle of pathogenic Listeria to
multiply intracellularly and spread from cell-to-cell with-
out leaving the protective environment of the host’s cells
[4]; the limited treatment options due to the negative side
effects of some of the antibiotics especially in pregnant
women, children, patients with allergies and in organ
transplant recipients [7]; the high mortality rate evendespite early antibiotic treatment [8] and the reports on
antibiotic resistance among Listeria species [9]. These
factors therefore, show the need for a continuous search
for newer and more effective listeriosis treatment options.
Medicinal plants have been used since time immemor-
ial to treat various types of illnesses and most have
formed the basis of some effective antimicrobial agents
[10]. In this connection this study focused on the anti-
Listerial activities of three triterpenes isolated from two
traditional medicinal plants namely Protorhus longifolia
and Mimusops caffra. Plant triterpenes comprise a di-
verse chemical group of active principles and have been
reported to possess anti-inflammatory, antiviral, anti-
microbial, and antitumor activities [11].
Protorhus longifolia is an evergreen plant that grows
up to a height of 18 m with a trunk diameter of about
1 m and belongs to the tropical and sub-tropical family
of Anacardiaceae [12]. The genus Protorhus Engl is
mostly found in Madagascar and only two species are found
in Africa namely Protorhus namaquensis (Namibian/South
African border) and Protorhus longifolia found in southern
parts of Africa, and mostly abundant in the sub-tropical for-
ests of KwaZulu Natal in South Africa [12]. The tea from
the mixture of the barks of Protorhus longifolia and
Hippobromus pauciflorus is known to treat heartwater
and diarrhea in cows [13]. Its leaf extracts have been
shown to possess both antibacterial and antifungal ac-
tivities in-vitro [14] and Mosa et al. [15] isolated two
triterpenes from the chloroform extract of the bark
namely 3-oxo-5α-lanosta-8,24-dien-21-oic acid and 3β-
hydroxylanosta-9,24-dien-21-oic acid, which exhibited
anti-platelet aggregation activities.
Mimusops caffra belongs to the Sapotaceae family and
the genus Mimusops consists of 30 species, some of which
grow in tropical and sub-tropical regions of Asia [16].
Mimusops caffra can be found in Southern Africa especially
in Mozambique and in the Kwazulu Natal and Eastern
Cape provinces of South Africa [17]. Its traditional me-
dicinal properties include wounds and sore healing
[17]. Ursolic acid isolated from the leaves of the plant,
was shown to exhibit anti-plasmodial activities against
Plasmodium falciparum (D10) [17].
Herein, this study provides a scientific basis for the anti-
Listeria activities of 3β-hydroxylanosta-9,24-dien-21-oic
acid and methyl-3β-hydroxylanosta-9,24-dien-21-oate iso-
lated from Protorhus longifolia and 3β-acetylursolic acid a




The 3β-hydroxylanosta-9,24-dien-21-oic acid and methyl-
3β-hydroxylanosta-9,24-dien-21-oate were previously iso-
lated and characterized from the stem bark of Protorhus
Figure 2 Chemical structure of methyl-3β-hydroxylanosta-9,
24-dien-21-oate [18].
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The 3β-acetylursolic acid was previously derivatised from
ursolic acid isolated from the leaves of Mimusops caffra by
Simelane et al. [17]. The chemical structures of the triter-
penes are as shown in Figures 1, 2 and 3.
Test antibiotics
The antibiotics penicillin G, ampicillin, neomycin and
gentamicin obtained from Sigma (South Africa) were used.
These were dissolved in sterile distilled water to make the
test concentration.
Test Listeria
The test Listeria was obtained from the culture collec-
tion of the Applied and Environmental Microbiology
Research Group (AEMREG) at the University of Fort
Hare, Alice, South Africa. The organisms included a ref-
erenced Listeria monocytogenes ATCC- 19115 strain as
well as environmental isolates of Listeria grayi (LAL 3)
and Listeria ivanovii (LDB 11) both previously isolated
from waste water effluents by Odjadjare et al. [19].
MIC determination
The MIC’s of the triterpenes were determined according
to the microbroth dilution method of EUCAST [20] as de-
scribed by Penduka and Okoh [21] in 96 well microtiter
plates. The test Listeria was standardised to match the 0.5
McFarland standard. A starting concentration of 5 mg/ml
of each triterpene dissolved in 10% DMSO was serially
diluted double fold in double strength Mueller-Hinton
Broth to make different test concentrations of the com-
pounds in the wells. A volume of 20 μl of the test organ-
isms was introduced to 100 μl of the test triterpene in
broth. The antibiotics penicillin G, ampicillin, neomycin
and gentamicin were used as positive controls. The 10%
DMSO was also tested for its possible anti-Listeria ac-
tivities. Sterility wells were also included and the whole
assay was perfomed in triplicates. The plates were then
incubated at 37°C for 18-24 h, after which results wereFigure 1 Chemical structure of 3β-Hydroxylanosta-9,
24-dien-21-oic acid [15].read visually by adding 40 μl of 0.2 mg/ml of ρ-
iodonitrotetrazolium violet (INT) into each well. A colour
change (viewing with the naked eye) from colourless to
purple, indicated actively growing bacteria based on the
oxidation-reduction reaction in which electrons are trans-
ferred from NADH (a product of the oxidation of threo-
nine to 2-amino-3-ketobutyrate) to INT which then forms
the red formazan which is purple in colour. The MIC was
recorded as the lowest concentration of the triterpene or
antibiotic that prevented the growth of the organism after
18-24 h.MBC determination
The MBC was determined using the method described by
Sudjana et al. [22] with some minor modifications. Briefly,
the test triterpenes and antibiotics were serially diluted in
double strength Mueller-Hinton broth in 96 well microti-
tre plates to make different test concentrations starting
with 8× MIC value of the test antibacterial agent up to its
MIC value against each organism. The test Listeria was
standardised to match the 0.5 McFarland standard and
20 μl of the organism was inoculated into each well
containing 100 μl of the test antibacterial agent in broth.Figure 3 Chemical structure of 3β-acetylursolic acid [17].
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was subcultured from each well and inoculated onto fresh
Mueller-Hinton agar plates. The agar plates were then in-
cubated for 18-24 h after which the MBC was interpreted
as the minimum concentration of the antibacterial agent
that prevented the growth of viable colonies on the
Mueller-Hinton agar after incubation.Interactions
The interactions between the triterpenes and selected
antibiotics were perfomed in 96 well microtiter plates as
described by Penduka et al. [23] using the chequer-
board method. The starting antimicrobial combination
in double strength Mueller-Hinton broth was serially di-
luted to make different test concentrations in the micro-
titer plate, with each well containing 100 μl of the test
antimicrobial combination. A volume of 20 μl of the stan-
dardised 0.5 MacFarland test bacteria was added into the
test wells. Sterility wells containing the broth only and
growth control wells containing the bacteria and broth
only were also added in each microtitre plate. The MIC’s
of the test combination were determined after 18-24 h of
incubation at 37°C using the same INT method men-
tioned in the MIC determination. The interactions were
interpreted through the use of Fractional Inhibitory Indi-
ces (FIC). The FIC index of a triterpene (FICT) was cal-
culated as the ratio of the MIC value of the triterpene in
combination over the MIC value of the triterpene alone,
and the FIC index of the antibiotic (FICA) was calculated
as the ratio of the MIC value of the antibiotic in com-
bination over the MIC value of the antibiotic alone. The
overall FIC index (ΣFIC) was calculated as the summa-
tion of the FICT and the FICA. The interactions were
interpreted as synergism when the ΣFIC index ≤ 0.5,
additive when 0.5 < ΣFIC index ≤ 1, and indifference
when 1 < ΣFIC index < 4 whilst antagonism was defined
as when the ΣFIC index is ≥4. The test was perfomed
in triplicates.Table 1 MIC determination of the triterpenes against the test
Test antibacterial agent L. mon
3β-hydroxylanosta-9,24-dien-21-oic acid (mg/ml) 0.185
methyl-3β-hydroxylanosta-9,24-dienoate (mg/ml) 0.185
3β-acetylursolic acid (mg/ml) 1.67
ampicillin (μg/ml) 0.014




Note: R denotes resistance towards the test antibacterial agent at a maximum testCytosolic lactate dehydrogenase assay for membrane
damage determination
The cytosolic lactate dehydrogenase assay was carried
out according to the methodology described by Soyingbe
et al. [24] with some modifications. Standardized test
Listeria cultures matching 0.5 MacFarland standard were
grown for 18-24 h in a concentration of 4× MIC value
of each triterpene after which, the mixture was centri-
fuged (5 000 × g for 5 mins). An aliquot of 50 μl from
the supernatant was incubated with 50 μl mixed reaction
solutions of a lactate dehydrogenase (LDH) activity assay
kit (Sigma Aldrich), at room temperature and incubated
for 30 min. After which, the absorbance was measured
at 492 nm using a 96 well microplate reader (BiotekELx
808). Cultures grown in 3% Triton X-100 were used as
the positive control. The extent of membrane damage was
calculated as (E-C)/(T-C) × 100, where E is the experimen-
tal absorbance of the cell cultures incubated with the test
triterpenes, C is the control absorbance of the cell medium
and T is the 3% Triton X-100 treated cells supernatant.
Statistical analysis




The MIC values of the triterpenes and the antibiotics are
as shown in Table 1. The triterpenes isolated from
P. longifolia had an MIC value of 0.185 mg/ml against all
the three test Listeria bacteria, while the 3β-acetylursolic
acid had an MIC value of 1.67 mg/ml against all the three
Listeria bacteria. The 10% DMSO was found not to exhibit
anti-Listeria activities in-vitro.
MBC determination
The results of the MBC determination are as shown in
Table 2. All the triterpenes were bacteriostatic against the
Listeria at a maximum concentration of 8× MIC value ofListeria bacteria









concentration of 100 μg/ml and NA denotes not active.
Table 2 MBC determination of the triterpenes against the test Listeria bacteria
Test antibacterial agent L. monocytogenes L.ivanovii L.grayi
3β-hydroxylanosta-9,24-dien-21-oic acid (mg/ml) >1.48 >1.48 >1.48
methyl-3β-hydroxylanosta-9,24-dienoate (mg/ml) >1.48 >1.48 >1.48
3β-acetylursolic acid (mg/ml) >13.36 >13.36 >13.36
ampicillin (μg/ml) >0.112 >0.04 R
penicillin G (μg/ml) > 0.632 >0.632 R
neomycin (μg/ml) >0.152 >1.26 10
gentamicin (μg/ml) >1.26 >1.26 5
Note: R denotes resistance towards the test antibacterial agent at a maximum test concentration of 100 μg/ml.
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bacteriostatic except for neomycin and gentamicin against
L. grayi whereby the antibiotics were bactericidal.
Interactions of the triterpenes and conventional antibiotics
The interactions of the triterpenes and conventional
antibiotics are as shown in Tables 3, 4, and 5. Penicillin
G had synergistic and additive interactions only, while
neomycin and gentamicin had interactions ranging from
synergistic to indifference and ampicillin had interac-
tions ranging from additive to antagonistic with the test
triterpenes.
Membrane damage activity of the triterpenes
The triterpenes showed low levels of cytosolic lactate
dehydrogenase release as shown in Table 6. The overall
highest cytosolic lactate dehydrogenase released was
18.8% against L. monocytogenes by 3β-hydroxylanosta-
9,24-dien-21-oic acid and the lowest being 0.02% against
L. ivanovii by 3β-hydroxylanosta-9,24-dien-21-oic acid .
Discussion
Triterpenes especially those isolated from medicinal plants
have a high potential of use as pharmacological agents
[11]. Plant compounds are usually classified as being anti-
microbial based on MIC ranges of 100 to 1000 μg/ml
while, those of typical antibiotics produced by bacteria or
fungi are acceptable antimicrobials at much lower ranges
of MICs between 0.01 and 10 μg/ml [25]. The triterpenes
used in this study showed appreciable antibacterial activ-
ities against the three Listeria species although the 3β-
acetylursolic acid had MICs outside the range acceptableTable 3 Interactions of 3β-hydroxylanosta-9,
24-dien-21-oic acid and the different antibiotics
L. grayi L. monocytogenes L. ivanovii
Ampicillin ND (1) Additive (1) Additive
Penicillin G ND (0.498) Synergy (0.498) Synergy
Neomycin (0.375) Synergy (0.75) Additive (0.497) Synergy
Gentamicin (0.245) Synergy (0.314) Synergy (1.25) Indifference
Note: ND denotes not determined and (number) denotes the ΣFIC index value.for plant compounds. The triterpenes even had activities
against L. grayi which was resistant towards the first line
antibiotics of choice ampicillin and penicillin G. L. grayi is
not normally a pathogenic species however, Salimnia et al.
[26] reported a case of L. grayi bacteremia in a stem cell
transplant recipient, showing the potential pathogenicity
of this species as well, such that reports of its resistance to
the penicillins are worrisome.
Combined therapy in listeriosis treatment is a well-
accepted concept as shown by the different treatment op-
tions against listeriosis mentioned previously [7,8]. In this
connection, interactions between the triterpenes and the
antibiotics in the penicillins (penicillin G and ampicillin)
and aminoglycosides (gentamicin and neomycin) groups
were tested in this study. Generally penicillin G had the
most favourable interactions with the triterpenes in com-
parison to all the other antibiotics as it had more syner-
gistic interactions with the triterpenes, while ampicillin
had the least favourable interactions. The contrasting
results observed between how the penicillins interacted
with the same triterpenes against the same organism
can be attributed to the differences in their chemical
structures. Penicillins consist of a thiazolidine ring con-
nected to a beta-lactam ring attached to a side chain.
Ampicillin has an amino group on the benzyl side chain
and this differentiates it from penicillin G of which the
side chain determines most pharmacologic characteris-
tics of each penicillin [27].
Generally 3β-hydroxylanosta-9,24-dien-21-oic acid was
the triterpene that exhibited mainly synergistic and addi-
tive interactions with all the antibiotics against all the
test Listeria. New findings of anti-Listeria agents thatTable 4 Interactions of methyl-3β-hydroxylanosta-9,
24-dien-21-oate and the different antibiotics
L. grayi L. monocytogenes L. ivanovii
Ampicillin ND (4) Antagonistic (4) Antagonistic
Penicillin G ND (0.498) Synergy (0.498) Synergy
Neomycin (1.5) Indifference (3.05) Indifference (1.01) Indifference
Gentamicin (1) Additive (0.314) Synergy (1.25) Indifference
Note: ND denotes not determined and (number) denotes the ΣFIC index value.
Table 5 Interactions of 3β-acetylursolic acid and the
different antibiotics
L. grayi L. monocytogenes L. ivanovii
Ampicillin ND (1.11) Indifference (1.11) Indifference
Penicillin G ND (1) Additive (0.498) Synergy
Neomycin (0.264) Synergy (1.06) Indifference (0.276) Synergy
Gentamicin (0.25) Synergy (0.156) Synergy (1.25) Indifference
Note: ND denotes not determined and (number) denotes the ΣFIC index value.
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conventional antibiotics against Listeria bacteria are sig-
nificant as the current combinations involving gentamicin
have nephrotoxicity risks [28,29], while those involving
sulfamethoxazole-trimethoprim have potential risks of
causing kernicterus to the foetus and folic acid metabol-
ism disturbances in pregnant women [7]. The triterpenes
used in this study have however, been found to be non-
toxic (with IC50 values that were higher than 300 μg/ml)
against some tested human cell lines [15,17,18]. Com-
pounds are considered significantly toxic when they have
an IC50 value of less than 30 μg/ml [17,30].
The MBC determination assay showed all the triter-
penes to be generally bacteriostatic against the Listeria
bacteria, however, in a bid to understand more on how
the triterpenes effect their anti-Listeria activities in-
vitro, the cytosolic lactate dehydrogenase test was car-
ried out to determine if membrane damage is their
mode of action. The results however, indicated that
membrane damage is not the main mode of action of
the triterpenes. This was evidenced by the low percent-
age of cytosolic lactate dehydrogenase released from the
cells treated with the triterpenes (Table 6). Essential oils
on the other hand which are typically a mixture of ter-
penes and/or terpenoids are postulated to exhibit anti-
bacterial activity by disrupting the permeability barrier
of microbial membrane structures [31], with some stud-
ies even showing the membrane disrupting activities of
some plants essential oils against both Gram negative
and Gram positive bacteria [24,31].
The findings of this study however, have shown mem-
brane damage by the triterpenes to be very minimal,
such that it can be hypothesised that the triterpenes act
on multiple target sites and their major mode of actionTable 6 Membrane damaging activity (% cytosolic lactate
dehydrogenase released) of the triterpenes against the
Listeria bacteria







3β-acetylursolic acid 0.334 0.090 2may include inhibition of macromolecular synthesis such
as DNA or RNA synthesis. The mechanism of action of
some triterpenoids against Gram positive bacteria have
also been shown to be a combination of plasma mem-
brane disruption and inhibition of macromolecular syn-
thesis such as RNA synthesis [32]. A study by Cristani
et al. [33] also showed that the antimicrobial activities of
some terpenes to be probably a resultant of partial agita-
tion of the lipidic fraction of the plasma membrane in
addition to the terpenes interacting with intracellular
sites which are critical for bacterial growth [33].
The resultant synergistic results observed in this study
can hypothetically be a combination of the protein synthe-
sis inhibition properties of the aminoglycosides [34] or the
cell wall inhibition properties of the penicillins (especially
penicillin G in this study) [35] and the macromolecular
synthesis inhibition properties of the triterpenes. In addition
to the findings of this study, some previous studies have
shown the methyl-3β-hydroxylanosta-9,24-dien-21-oate
and 3β-hydroxylanosta-9,24-dien-21-oic acid to possess
anti-inflammatory, anti-hyperlipidemic, anti-coagulant
activities [15,18], while the 3β-acetylursolic acid has been
shown to possess anti-plasmodial activities [17].The vari-
ous bioactivities of the triterpenes together show their
multiple beneficial health effects potentials, such that their
use in listeriosis treatment especially in the immune-
compromised is highly likely to be advantageous.
Conclusion
The three triterpenes tested possessed varying levels of
anti-Listeria activities and also some synergistic interac-
tions with conventional listeriosis treatment antibiotics in-
vitro showing their potential in alternative listeriosis treat-
ment. A follow up of the study with in-vivo tests would be
highly recommended to ascertain if the observed in-vitro
results align with the in-vivo results and also to determine
if the synergistic interactions observed also result in
bactericidal action.
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